Drug Shortage Report for RENVELA
| Report ID | 233720 |
| Drug Identification Number | 02485559 |
| Brand name | RENVELA |
| Common or Proper name | Sevelamer carbonate |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | SEVELAMER CARBONATE |
| Strength(s) | 0.8G |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL ORAL |
| Packaging size | Sachet |
| ATC code | V03AE |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2024-07-22 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-10-01 |
| Company comments | The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. Patients should validate the availability of the product with their respective pharmacy. Pending additional documentation. |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-10-01 | French | Compare |
| v3 | 2024-10-01 | English | Compare |
| v2 | 2024-07-26 | French | Compare |
| v1 | 2024-07-26 | English | Compare |
Showing 1 to 4 of 4